Advertisement

Topics

twoXAR, Inc. Company Profile

17:09 EDT 18th June 2018 | BioPortfolio

Founded in 2014 by two entrepreneurs named Andrew Radin, twoXAR is transforming how large biological datasets are harnessed to accelerate the identification and validation of new medicines. Based in Palo Alto, California, the twoXAR team includes experts in drug discovery, biomedical informatics, computational biology, data science, software development and preclinical validation. For more information please visit, www.twoXAR.com.


News Articles [13 Associated News Articles listed on BioPortfolio]

TwoXAR Lands $10M to Ramp Up AI-Based Drug Discovery Work

Drug discovery startup twoXAR has raised $10 million in funding to support its efforts to build a pipeline of drug candidates found by its proprietary artificial intelligence technology. SoftBank Vent...

Series A lands $10mm for twoXAR

TwoXAR Inc. (using artificial intelligence in drug discovery) raised $10mm in a Series A financing led by SoftBank Ventures, which was joined by OS Fund and returning shareholder Andreessen Horowitz B...

Seed round brings in $3.4mm for twoXAR

One-year-old twoXAR (artificial intelligence-based drug discovery) raised $3.4mm in seed financing led by Andreessen Horowitz, which was joined by returning shareholders CLI Ventures and the Stanford-...

AI Drug Developer TwoXAR Raises $10m In Series A

Californian biopharma, TwoXAR, which is using a computational platform to identify drug candidates, de-risks opportunities through preclinical studies, and progresses...   

AI company twoXAR raises $10M series A

Bioinformatics startup twoXAR bags $10M in Series A

The company, which is using an AI-based platform to comb through drug candidates in a much shorter time than traditional approaches require, just raised $10 million.

Bioinformatics startups twoXAR bags $10M in Series A

The company, which is using an AI-based platform to comb through drug candidates in a much shorter time than traditional approaches require just raised $10 million.

SoftBank Ventures Leads $10M Investment in AI-Driven Drug Discovery Company twoXAR

Andreessen Horowitz and OS Fund participate in Series A investment which will be used to build a portfolio of drug programs through biopharmaceutical partnerships twoXA...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

twoXAR, Inc.

Founded in 2014 by two entrepreneurs named Andrew Radin, twoXAR is transforming how large biological datasets are harnessed to accelerate the identification and validation of new ...

More Information about "twoXAR, Inc." on BioPortfolio

We have published hundreds of twoXAR, Inc. news stories on BioPortfolio along with dozens of twoXAR, Inc. Clinical Trials and PubMed Articles about twoXAR, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of twoXAR, Inc. Companies in our database. You can also find out about relevant twoXAR, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record